Wolverine Trading’s Calumet Specialty Products CLMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.33M | Buy |
125,944
+104,810
| +496% | +$1.72M | ﹤0.01% | 2045 |
|
|
2025
Q2 | $328K | Sell |
21,134
-32,242
| -60% | -$410K | ﹤0.01% | 3385 |
|
|
2025
Q1 | $702K | Sell |
53,376
-115,545
| -68% | -$1.81M | ﹤0.01% | 2582 |
|
|
2024
Q4 | $3.67M | Buy |
168,921
+25,566
| +18% | +$538K | ﹤0.01% | 1444 |
|
|
2024
Q3 | $2.51M | Buy |
+143,355
| New | +$2.3M | ﹤0.01% | 1524 |
|
|
2024
Q2 | – | Sell |
-16,941
| Closed | -$252K | – | 4560 |
|
|
2024
Q1 | $252K | Buy |
+16,941
| New | +$270K | ﹤0.01% | 3554 |
|
|
2023
Q4 | – | Sell |
-25,723
| Closed | -$417K | – | 4556 |
|
|
2023
Q3 | $491K | Buy |
25,723
+4,326
| +20% | +$74.9K | ﹤0.01% | 2789 |
|
|
2023
Q2 | $341K | Buy |
21,397
+9,843
| +85% | +$162K | ﹤0.01% | 2956 |
|
|
2023
Q1 | $197K | Sell |
11,554
-5,061
| -30% | -$89.9K | ﹤0.01% | 3427 |
|
|
2022
Q4 | $280K | Sell |
16,615
-15,854
| -49% | -$256K | ﹤0.01% | 2822 |
|
|
2022
Q3 | $427K | Buy |
+32,469
| New | +$466K | ﹤0.01% | 2783 |
|
|
2022
Q1 | – | Sell |
-46,797
| Closed | -$599K | – | 5517 |
|
|
2021
Q4 | $599K | Buy |
46,797
+29,017
| +163% | +$365K | ﹤0.01% | 3235 |
|
|
2021
Q3 | $135K | Sell |
17,780
-24,814
| -58% | -$171K | ﹤0.01% | 5617 |
|
|
2021
Q2 | $293K | Buy |
42,594
+26,251
| +161% | +$162K | ﹤0.01% | 4451 |
|
|
2021
Q1 | $96K | Buy |
+16,343
| New | +$68.2K | ﹤0.01% | 5446 |
|
|
2020
Q4 | – | Sell |
-10,568
| Closed | -$36.8K | – | 4863 |
|
|
2020
Q3 | $28K | Sell |
10,568
-1,933
| -15% | -$4.97K | ﹤0.01% | 4359 |
|
|
2020
Q2 | $29K | Buy |
+12,501
| New | +$26.7K | ﹤0.01% | 4393 |
|
|
2020
Q1 | – | Sell |
-43,883
| Closed | -$160K | – | 4690 |
|
|
2019
Q4 | $160K | Sell |
43,883
-16,530
| -27% | -$57.1K | ﹤0.01% | 4127 |
|
|
2019
Q3 | $227K | Sell |
60,413
-25,416
| -30% | -$109K | ﹤0.01% | 3443 |
|
|
2019
Q2 | $360K | Sell |
85,829
-18,022
| -17% | -$72.1K | ﹤0.01% | 3075 |
|
|
2019
Q1 | $370K | Buy |
103,851
+87,454
| +533% | +$291K | ﹤0.01% | 3119 |
|
|
2018
Q4 | $35K | Sell |
16,397
-177,343
| -92% | -$732K | ﹤0.01% | 4220 |
|
|
2018
Q3 | $1.24M | Buy |
193,740
+96,724
| +100% | +$686K | ﹤0.01% | 2113 |
|
|
2018
Q2 | $684K | Hold |
97,016
| – | – | ﹤0.01% | 2671 |
|
|
2018
Q1 | $684K | Sell |
97,016
-26,653
| -22% | -$197K | ﹤0.01% | 2671 |
|
|
2017
Q4 | $952K | Buy |
123,669
+90,663
| +275% | +$756K | ﹤0.01% | 2258 |
|
|
2017
Q3 | $276K | Buy |
33,006
+4,499
| +16% | +$28K | ﹤0.01% | 3372 |
|
|
2017
Q2 | $120K | Buy |
+28,507
| New | +$114K | ﹤0.01% | 3836 |
|
|
2017
Q1 | – | Sell |
-27,411
| Closed | -$109K | – | 4328 |
|
|
2016
Q4 | $110K | Sell |
27,411
-7,550
| -22% | -$30.8K | ﹤0.01% | 4027 |
|
|
2016
Q3 | $165K | Buy |
+34,961
| New | +$180K | ﹤0.01% | 3942 |
|
Other funds holding CLMT
WDOM
TSC
AAA
DMKJ
Wolverine Trading's CLMT Position: Q3 2025 in Review
Wolverine Trading increased its Calumet Specialty Products (CLMT) stake by 496% in Q3 2025, buying an estimated $1.72M and bringing the position to 125,944 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2045.
Wolverine Trading first reported a position in CLMT in Q3 2016 and has held it in 30 quarters since. The position peaked at $3.67M in Q4 2024. 149 funds tracked by Wall St. Rank hold CLMT as of Q3 2025.
- Wolverine Trading held 125,944 shares of Calumet Specialty Products worth $2.33M as of Q3 2025.
- Wolverine Trading bought 104,810 Calumet Specialty Products shares in Q3 2025, an estimated $1.72M.
- Calumet Specialty Products made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2045 holding.
- Wolverine Trading first reported a position in Calumet Specialty Products in Q3 2016 and has held it in 30 quarters since.
- Wolverine Trading's Calumet Specialty Products position peaked at $3.67M in Q4 2024.
- 149 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.